These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12172367)

  • 1. Characteristics of hepatitis C in renal transplant candidates.
    Cotler SJ; Diaz G; Gundlapalli S; Jakate S; Chawla A; Mital D; Jensik S; Jensen DM
    J Clin Gastroenterol; 2002 Aug; 35(2):191-5. PubMed ID: 12172367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients.
    Glicklich D; Thung SN; Kapoian T; Tellis V; Reinus JF
    Am J Gastroenterol; 1999 Jan; 94(1):159-63. PubMed ID: 9934748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-stage renal disease and hepatitis C infection: comparison of alanine aminotransferase levels and liver histology in patients with and without renal damage.
    Contreras AM; Ruiz I; Polanco-Cruz G; Monteón FJ; Celis A; Vázquez G; Gómez-Herrera E; García-Correa JE; Male-Velázquez R; Ruelas-Hernández S
    Ann Hepatol; 2007; 6(1):48-54. PubMed ID: 17297429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney transplantation alone in ESRD patients with hepatitis C cirrhosis.
    Paramesh AS; Davis JY; Mallikarjun C; Zhang R; Cannon R; Shores N; Killackey MT; McGee J; Saggi BH; Slakey DP; Balart L; Buell JF
    Transplantation; 2012 Aug; 94(3):250-4. PubMed ID: 22790385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation.
    Sterling RK; Sanyal AJ; Luketic VA; Stravitz RT; King AL; Post AB; Mills AS; Contos MJ; Shiffman ML
    Am J Gastroenterol; 1999 Dec; 94(12):3576-82. PubMed ID: 10606322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous liver biopsy is safe in chronic hepatitis C patients with end-stage renal disease.
    Pawa S; Ehrinpreis M; Mutchnick M; Janisse J; Dhar R; Siddiqui FA
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1316-20. PubMed ID: 17904916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():159-64. PubMed ID: 25894147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological features of hepatitis C in renal transplant candidates [see comment].
    Martin P; Carter D; Fabrizi F; Dixit V; Conrad AJ; Artinian L; Peacock V; Han S; Wilkinson A; Lassman CR; Danovitch G
    Transplantation; 2000 Apr; 69(7):1479-84. PubMed ID: 10798774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal transplantation offers a better survival in HCV-infected ESRD patients.
    Sezer S; Ozdemir FN; Akcay A; Arat Z; Boyacioglu S; Haberal M
    Clin Transplant; 2004 Oct; 18(5):619-23. PubMed ID: 15344970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is hepatitis C more aggressive in renal transplant patients than in patients with end-stage renal disease?
    Perez RM; Ferreira AS; Medina-Pestana JO; Cendoroglo-Neto M; Lanzoni VP; Silva AE; Ferraz ML
    J Clin Gastroenterol; 2006; 40(5):444-8. PubMed ID: 16721229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients.
    Rao KV; Anderson WR; Kasiske BL; Dahl DC
    Am J Med; 1993 Mar; 94(3):241-50. PubMed ID: 8452147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features of hepatitis C virus infection in dialysis and renal transplantation.
    Töz H; Ok E; Yilmaz F; Akarca US; Erensoy S; Zeytinoğlu A; Ozkahya M; Karasu Z; Yüce G; Başçi A
    J Nephrol; 2002; 15(3):308-12. PubMed ID: 12116989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic features of hepatitis C virus infection in renal allograft recipients.
    Chan TM; Wu PC; Lau JY; Lai CL; Lok AS; Cheng IK
    Transplantation; 1994 Nov; 58(9):996-1000. PubMed ID: 7974739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can aminotransferase-to-platelet ratio index and other non-invasive markers effectively reduce liver biopsies for renal transplant evaluation of hepatitis C virus-positive patients?
    Jiang Y; Huang E; Mehrnia A; Kamgar M; Pham PT; Ogunorunyinka O; Brown I; Danovitch GM; Bunnapradist S
    Nephrol Dial Transplant; 2014 Jun; 29(6):1247-52. PubMed ID: 24353319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C infection in potential recipients with normal liver biochemistry does not preclude renal transplantation.
    Kazi S; Prasad S; Pollak R; Holzer T; Heynen C; Fabrega AJ; Pitrak D; Layden TJ
    Dig Dis Sci; 1994 May; 39(5):961-4. PubMed ID: 7513631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular liver biopsy in patients with end-stage renal disease.
    Ahmad A; Hasan F; Abdeen S; Sheikh M; Kodaj J; Nampoory MR; Johny KV; Asker H; Siddique I; Thalib L; Al-Nakib B
    J Vasc Interv Radiol; 2004 Mar; 15(3):257-60. PubMed ID: 15028810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal transplant in hepatitis B and C positive patients--a ten years experience.
    Rathod JR; Sirsat RA; Shah BV
    J Assoc Physicians India; 2002 Jun; 50():766-70. PubMed ID: 12240839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hepatitis C-induced liver fibrosis on survival in kidney transplant candidates.
    Campbell MS; Constantinescu S; Furth EE; Reddy KR; Bloom RD
    Dig Dis Sci; 2007 Oct; 52(10):2501-7. PubMed ID: 17394069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.
    Rostaing L; Izopet J; Cisterne JM; Arnaud C; Duffaut M; Rumeau JL; Puel J; Durand D
    Transplantation; 1998 Apr; 65(7):930-6. PubMed ID: 9565097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of genotype and markers of disease severity of chronic hepatitis C in patients with and without end-stage renal disease.
    Hassan MR; Mustapha NR; Zawawi FM; Earnest BS; Voralu K; Pani SP
    Singapore Med J; 2011 Feb; 52(2):86-9. PubMed ID: 21373733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.